BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 33620180)

  • 1. A Novel Nomogram for Survival Prediction of Patients with Spinal Metastasis From Prostate Cancer.
    Liu Y; Li L; Jiang D; Yang M; Gao X; Lv K; Xu W; Wei H; Wan W; Xiao J
    Spine (Phila Pa 1976); 2021 Mar; 46(6):E364-E373. PubMed ID: 33620180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel model for predicting survival of patients with spine metastasis from colorectal cancer.
    Liu Y; Yang M; Li B; Xu K; Gao X; Li J; Wei H; Huang Q; Xu W; Xiao J
    Eur Spine J; 2019 Jun; 28(6):1491-1501. PubMed ID: 30659348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Novel Survival Prediction Model in Patients With Spinal Metastasis From Non-small Cell Lung Cancer.
    Yang M; Xu W; Liu T; Yang X; Wang P; Wu S; Wei H; Zhao J; Yang C; Xiao J
    Spine (Phila Pa 1976); 2019 Feb; 44(4):246-257. PubMed ID: 30059487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and validation of nomogram model for survival predicting in patients with spinal metastases secondary to lung cancer.
    Gao ZY; Zhang T; Zhang H; Pang CG; Jiang WX
    Neurol Res; 2021 Apr; 43(4):327-335. PubMed ID: 33377432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting survival for metastatic spine disease: a comparison of nine scoring systems.
    Ahmed AK; Goodwin CR; Heravi A; Kim R; Abu-Bonsrah N; Sankey E; Kerekes D; De la Garza Ramos R; Schwab J; Sciubba DM
    Spine J; 2018 Oct; 18(10):1804-1814. PubMed ID: 29567516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Traditional Prognosis Scoring Systems and Skeletal Oncology Research Group Nomogram for Predicting Survival of Spinal Metastasis Patients Undergoing Surgery.
    Chanplakorn P; Budsayavilaimas C; Jaipanya P; Kraiwattanapong C; Keorochana G; Leelapattana P; Lertudomphonwanit T
    Clin Orthop Surg; 2022 Dec; 14(4):548-556. PubMed ID: 36518924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a SEER-based prognostic nomogram for patients with bone metastatic prostate cancer.
    Hou G; Zheng Y; Wei D; Li X; Wang F; Tian J; Zhang G; Yan F; Zhu Z; Meng P; Yuan J; Gao M; Li Z; Zhang B; Xing Z; Yuan J
    Medicine (Baltimore); 2019 Sep; 98(39):e17197. PubMed ID: 31574827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram for Individualized Prediction and Prognostic Factors for Survival in Patients with Primary Spinal Chordoma: A Population-Based Longitudinal Cohort Study.
    Huang JF; Chen D; Sang CM; Zheng XQ; Lin JL; Lin Y; Ni WF; Wang XY; Li YM; Wu AM
    World Neurosurg; 2019 Aug; 128():e603-e614. PubMed ID: 31054340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prediction value of PI-RADS v2 score in high-grade Prostate Cancer: a multicenter retrospective study.
    Chen S; Yang Y; Peng T; Yu X; Deng H; Guo Z
    Int J Med Sci; 2020; 17(10):1366-1374. PubMed ID: 32624693
    [No Abstract]   [Full Text] [Related]  

  • 10. Survival analysis and development of a prognostic nomogram for bone-metastatic prostate cancer patients: A single-center experience in Indonesia.
    Afriansyah A; Hamid ARA; Mochtar CA; Umbas R
    Int J Urol; 2019 Jan; 26(1):83-89. PubMed ID: 30269369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of Nomograms Predicting Overall and Cancer-Specific Survival of Spinal Chondrosarcoma Patients.
    Song K; Song J; Shi X; Wang H; Ma X; Xia X; Liang X; Lin K; Jiang J
    Spine (Phila Pa 1976); 2018 Nov; 43(21):E1281-E1289. PubMed ID: 29664813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SORG nomogram accurately predicts 3- and 12-months survival for operable spine metastatic disease: External validation.
    Paulino Pereira NR; Mclaughlin L; Janssen SJ; van Dijk CN; Bramer JAM; Laufer I; Bilsky MH; Schwab JH
    J Surg Oncol; 2017 Jun; 115(8):1019-1027. PubMed ID: 28346699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus.
    Duan F; Song C; Ma Y; Jiang K; Xu F; Bi X; Huang J; Hong R; Huang Z; Lu Q; Yuan Z; Wang S; Xia W
    Drug Des Devel Ther; 2021; 15():3463-3473. PubMed ID: 34408400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a prognostic nomogram for the overall survival of patients living with spinal metastases.
    Yang XG; Feng JT; Wang F; He X; Zhang H; Yang L; Zhang HR; Hu YC
    J Neurooncol; 2019 Oct; 145(1):167-176. PubMed ID: 31549282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Nomogram for Predicting Cancer-Specific Survival in Patients With Spinal Chordoma: A Population-Based Analysis.
    Huang Z; Fan Z; Zhao C; Sun H
    Technol Cancer Res Treat; 2021; 20():15330338211036533. PubMed ID: 34382474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nomogram based on peripheral lymphocyte for predicting 8-year survival in patients with prostate cancer: a single-center study using LASSO-cox regression.
    Chen J; Yu F; He G; Hao W; Hu W
    BMC Cancer; 2024 Feb; 24(1):254. PubMed ID: 38395827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram for predicting the overall survival of patients with early-onset prostate cancer: A population-based retrospective study.
    Hu Y; Qi Q; Zheng Y; Wang H; Zhou J; Hao Z; Meng J; Liang C
    Cancer Med; 2022 Sep; 11(17):3260-3271. PubMed ID: 35322943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
    Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
    J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
    Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.